FDA Drug recall D-0626-2026
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactu…
- FDA Drug
- Class II
- ongoing
- Published 2026-07-01
On 2026-07-01 the FDA classified a Class II recall of Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactu… by Annora Pharma Private, citing presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0626-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-06-04 |
| Published | 2026-07-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Annora Pharma Private |
| Distribution | US |
Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Reason
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Identifiers
| ndc | 31722-812-60 |
|---|---|
| ndc | 31722-812-18 |
| ndc | 31722-812-05 |
| ndc | 31722-812-32 |
| ndc | 31722-813-60 |
| ndc | 31722-813-18 |
| ndc | 31722-813-05 |
| ndc | 31722-813-32 |
| ndc | 31722-814-60 |
| ndc | 31722-814-18 |
| ndc | 31722-814-05 |
| ndc | 31722-814-32 |
| ndc | 31722-815-60 |
| ndc | 31722-815-18 |
| ndc | 31722-815-05 |
| ndc | 31722-815-32 |
| code_info | Lot: A253999, A254000, Expires: 09/30/2027. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0626-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.